Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Charles Ascher-Walsh is a leading figure in minimally invasive gynecologic surgery, with a particular focus on the surgical management of uterine fibroids (leiomyomas) and pelvic organ prolapse. His most influential work, a 2010 study with 95 citations, demonstrated that robot-assisted laparoscopic myomectomy is a significant improvement over traditional laparotomy for women with a limited number of fibroids, helping to shift surgical practice toward less invasive approaches. He has also made critical contributions to understanding the impact of myomectomy on ovarian reserve, showing in a prospective cohort study that the procedure does not significantly diminish anti-Müllerian hormone (AMH) levels. Dr. Ascher-Walsh’s research extends to comparative effectiveness, analyzing nationwide databases to evaluate surgical complications and hospital costs between robotic and conventional laparoscopic hysterectomy with sacrocolpopexy. His work is characterized by a patient-centered approach, as evidenced by studies on patient preferences for abdominal incisions in prolapse surgery and innovations in patient positioning during laparoscopy. With a career dedicated to improving surgical outcomes and quality of life for women, Dr. Ascher-Walsh remains a pivotal voice in advancing evidence-based, minimally invasive gynecologic care.